Related Experiment Video
Updated: Jul 14, 2026
07:19
A Modified Lean and Release Technique to Emphasize Response Inhibition and Action Selection in Reactive Balance
Published on: March 19, 2020
Optimizing the pharmacological component of integrated balance therapy
Maurício Malavasi Ganança1, Heloisa Helena Caovilla, Mário Sérgio Lei Munhoz
1Federal University of São Paulo, São Paulo, Brazil. mauricio.gananca@globo.com
Brazilian Journal of Otorhinolaryngology
|May 17, 2007
Summary
Betahistine proved most effective for Ménière
Area of Science:
- Vestibular system disorders
- Pharmacological interventions
- Balance therapy
Background:
- Peripheral vestibular diseases significantly impact quality of life.
- Integrated Balance Therapy (IBT) is a key treatment approach.
- Identifying optimal pharmacotherapy within IBT is crucial.
Purpose of the Study:
- To determine the most effective drug component for Integrated Balance Therapy (IBT).
- To compare various medications in treating Ménière's disease and other peripheral vestibular disorders.
Main Methods:
- A comparative analysis of patients with Ménière's disease and other peripheral vestibular disorders.
- Patients received IBT with either no medication, betahistine, cinnarizine, clonazepam, flunarizine, or Ginkgo biloba over 120 days.
Main Results:
- All tested drug therapies showed greater efficacy than no medication for both conditions.
- Betahistine demonstrated superior effectiveness in Ménière's disease patients at 60 and 120 days.
- For non-Ménière's disorders, betahistine, cinnarizine, and clonazepam were equally effective and superior to flunarizine and Ginkgo biloba.
Conclusions:
- Pharmacological interventions enhance the effectiveness of IBT for peripheral vestibular disorders.
- Betahistine is the leading medication for Ménière's disease.
- Betahistine, cinnarizine, and clonazepam offer comparable efficacy for other peripheral vestibular disorders.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...